eIF2D Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF2D monoclonal antibodies for research focused on understanding eIF2D's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF2D, or eukaryotic translation initiation factor 2D, plays a critical role in the initiation of protein synthesis by facilitating the assembly of the translation initiation complex. eIF2D is essential for the regulation of gene expression and cellular response to stress, making it a key player in various biological processes, including cell growth and differentiation. Understanding eIF2D function is vital for elucidating mechanisms underlying diseases such as cancer and neurodegenerative disorders. Researchers worldwide rely on eIF2D monoclonal antibodies to advance their studies in protein synthesis and cellular regulation. The specificity and reliability of eIF2D monoclonal antibodies enable precise detection and analysis of eIF2D expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies for eIF2D contribute to advancing scientific knowledge in molecular biology and disease research.